ArticleDermatology and therapy2023

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study.

Akihiko Asahina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.